Clinic Software← All companies
Sidekick Bio
Helping immunotherapy realize its full potential to treat cancer - through the gut microbiome.
health AI / biotech / medtech (microbiome-based cancer immunotherapy)
StageSidekick Bio has not raised funding (as of reported data)
Founded2022
Employees3
LocationBoston, MA
Business modelB2B / B2C / biopharma development (biotech startup)
Valuation$1.4M (estimated)
About
Sidekick Bio is a biopharmaceutical company developing therapies that modulate the gut microbiome to improve the safety and efficacy of cancer immunotherapy. Based in Boston, the company aims to enable more patients with cancer to achieve durable responses by advancing microbiome-based medicine.
Product
- Value proposition
- Biopharmaceutical company developing therapies that modulate the gut microbiome to improve safety and efficacy of cancer immunotherapy and enable more patients to achieve a durable response.
- Target customers
- pharma/biotech partners, clinical researchers, oncology sponsors
Founders
- Johan van Hylckama Vlieg — Co-founder and scientific advisor
- Ulrich Binné — Co-founder, COO, and Head of Legal
Categories
Products
therapies that alter the gut microbiome to improve safety and efficacy of cancer immunotherapy
Key features
modulates gut microbiomeaims to improve safety and efficacy of immunotherapyfocus on durable responses in canceradvances microbiome-based medicine
Technologies
microbiome modulationbiopharmaceutical development
Target conditions
cancercancer immunotherapy outcomes
Care settings
clinical settingshospitalresearch and developmentlaboratorybiotech startup environment
News
- List of Microbiome Companies in Massachusetts - BiopharmIQ · 2025-06-06T00:00:00.000Z
- Iceland: Sidekick Health Secures €35 Million Venture Debt from EIB to Accelerate R&D and Global Expansion · 2025-04-30T11:45:00.000Z
- Sidekick Health Cracks the Code on Medication Adherence -- Driving Better Outcomes and Lower Costs · 2025-04-14T11:00:00.000Z
- Iceland: Sidekick Health Secures €35 Million Venture Debt from EIB to Accelerate R&D and Global Expansion - The European Sting - Critical News & Insights on European Politics, Economy, Foreign Affairs, Business & Technology - europeansting.com - · 2025-05-05T09:43:22.000Z
- Sidekick Health Secures $35M to Revolutionize Digital Therapeutics for Multi-Chronic Care | Signalbase · 2025-05-07T16:20:03.000Z
- Transforming Medication Management for Better Patient Care - Investors Hangout · 2025-04-14T11:25:04.000Z
